Discontinuation report NOVAHISTINE DH

Last updated on 2020-08-04 History
Report ID 98377
Drug Identification Number 02049473
Brand name NOVAHISTINE DH
Common or Proper name Novahistine DH
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Strength(s) 10MG 1.7MG
Dosage form(s) SYRUP
Route of administration ORAL
Packaging size 100ml
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-06-30
Actual discontinuation date 2020-07-10
Remaining supply date 2020-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments last lot 8115892 expiry 2021-10-17
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-08-04 French Compare
v5 2020-08-04 English Compare
v4 2020-08-03 French Compare
v3 2020-08-03 English Compare
v2 2019-11-11 French Compare
v1 2019-11-11 English Compare